Orange County Bancorp, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Orange County Bancorp, Inc. (the "Company") on June 3, 2025. The Company, an emerging growth company incorporated in Delaware, operates through its subsidiary, Orange Bank & Trust Company. The report details a material definitive agreement entered into on June 3, 2025, regarding a registered public offering of common stock.
Key Financial Metrics and Transaction Details
- Transaction Type: Underwriting agreement for a registered public offering of common stock.
- Shares Issued: 1,720,430 shares of Common Stock, par value $0.25 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 258,064 shares.
- Estimated Net Proceeds: Approximately $37.5 million, after deducting underwriting discounts, commissions, and estimated offering expenses.
- Expected Closing Date: June 5, 2025.
- Underwriter: Piper Sandler & Co., as representative of the underwriters.
Material Changes and Comparisons
This filing represents a discrete capital raising event rather than a periodic financial performance report. Consequently, the document does not provide comparative revenue, profit, cash flow, margin, or debt metrics against prior periods. The primary material change is the anticipated increase in the Company's equity capital and cash liquidity upon the closing of the offering.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance regarding future earnings or operational outlook beyond the completion of the offering. The Underwriting Agreement includes customary representations, warranties, conditions to closing, and indemnification obligations. The Company notes that the information furnished is not intended to constitute a determination that the information is material or complete for investment decision-making purposes outside of the specific context of the offering.
Key Facts for Investor Verification
- Verify the final closing date of the offering, currently expected to be June 5, 2025.
- Confirm whether the underwriters exercise the 30-day option to purchase the additional 258,064 shares.
- Review the final prospectus supplement for the exact offering price per share, which is not explicitly stated in this summary text.
- Monitor the Company's subsequent filings for the actual net proceeds received and the specific allocation of these funds.
- Check for any updates regarding the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.